Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), with a substantial market capitalization of $110.13 billion, continues to ...

Vertex (VRTX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

Vertex Pharmaceuticals (VRTX ... its future stream of earnings is what determines the fair value for its stock. Our analysis is essentially based on how sell-side analysts covering the stock ...

CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...

Vertex Securities Ltd share price was up by ... All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

In the digital advertising space, YouTube's direct response (DR) strength, especially with QR codes, has been well-received ...

A look at Intellia Therapeutics, Inc. and Editas Medicine, Inc., including their restructuring and pipeline prioritization.

NYSE:EPAM) EPAM Expands Collaboration with Google Cloud to Deliver Scalable AI Solutions for Industry Transformation ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

For the week ended Jan. 17, 29 stocks saw their Morningstar Ratings change to 2 stars, while three climbed into 1-star ...